Qubits Surpass Quantum Boundaries, Enabling Extended Information Encoding

Quantum particles now have an extended capacity to carry useful information.

koto_feja/Getty Images

The intriguing phenomenon of quantum superposition has enabled scientists to surpass the limitations imposed by fundamental quantum mechanics, equipping quantum objects with properties advantageous for long-term quantum computing.

For over a century, physicists have wrestled with the challenge of distinguishing between the minuscule quantum world and the larger macroscopic universe. In 1985, physicists Anthony Leggett and Anupam Garg introduced a mathematical assessment for determining the size threshold at which an object transcends its quantum characteristics. Quantum objects are recognized by remarkably strong correlations of their properties over time, akin to surprising connections between actions of yesterday and tomorrow.

Objects that achieve a sufficient score in this assessment are classified as quantum, with the scores traditionally held back by a value known as the temporal Zirelson limit (TTB). Theorists believed that even distinctly quantum objects could not surpass this threshold. However, Arijit Chatterjee and his colleagues from the Indian Institute of Science Education and Research in Pune have discovered a method to significantly exceed the TTB using one of the most basic quantum elements.

They centered their research on qubits, the essential building blocks of quantum computers and other quantum information systems. While qubits can be produced through various methods, the team utilized a carbon-based molecule incorporating three qubits. The first qubit was employed to control the behavior of the second “target” qubit over time, with the third qubit employed to extract properties from the target.

Though three-qubit configurations are generally believed to be constrained by the TTB, Chatterjee and his team discovered a method to push the target qubits beyond this limitation dramatically. In fact, their technique resulted in one of the most significant deviations from mathematical plausibility. The key was for the first qubit to govern the target qubit while it was in a state of quantum superposition, where it can effectively embody two states or actions that seem mutually exclusive. For instance, in their experiment, the first qubit directed the target qubit to rotate both clockwise and counterclockwise simultaneously.

Qubits are usually susceptible to decoherence over time, diminishing their capacity to store quantum information. However, after the target qubit surpassed the TTB, decoherence set in, yet the ability to encode information persisted five times longer due to its time-controlled behavior influenced by superposition.

According to Chatterjee, this resilience is advantageous in any context requiring precise qubit control, such as in computational applications. Team member HS Kartik from Poland’s University of Gdańsk mentions that procedures in quantum metrology, including accurate sensing of electromagnetic fields, could benefit significantly from this level of qubit control.

Rakura and their colleagues from China’s Sun Yat-sen University indicate that this research not only has clear potential for enhancing quantum computing practices but also fundamentally broadens our comprehension of how quantum objects behave over time. This is significant because immensely surpassing the TTB indicates that the properties of the qubit are highly interconnected at two divergent time points, a phenomenon absent in non-quantum entities.

The substantial breach of the TTB strongly demonstrates the extent of quantum characteristics present throughout the three-qubit configuration and exemplifies how researchers are advancing the frontiers of the quantum domain, says Karthik.

Topics:

  • quantum computing/
  • quantum physics

Source: www.newscientist.com

Introducing the Smart Pill: Enabling Doctors to Examine and Treat Your Intestines Internally.

Emerging technologies enable doctors to leverage microorganisms for diagnosing and treating diseases through gut microbiota. Recent studies highlight these advancements.

Researchers successfully used smartphone apps to genetically alter bacteria, causing them to emit light signals in response.

If proven safe and effective in humans, this treatment could address several illnesses that are currently challenging to manage.

This method encompassed three key elements: bacteria, technology, and pigs. Under the guidance of senior author Hanzi Wang from Tianjin University in China, scientists modified E. coli bacteria to react to specific chemical and optical stimuli.

They created swallowable capsules controlled via Bluetooth that communicate with these photoresponsive bacteria, targeting pigs afflicted with colitis, a type of inflammatory bowel disease that results in intestinal swelling.

The experiment has commenced, allowing scientists to introduce engineered E. coli into the inflamed intestines of pigs through these capsules.

Nitrates, which the body produces during intestinal inflammation, serve as indicators of active colitis. When the modified E. coli come into contact with nitrates, they illuminate.

These smart capsules can detect the optical signal, alerting researchers to the presence of E. coli via Bluetooth.

Through a smartphone app, researchers can command the capsule to start emitting light signals, prompting the E. coli to release anti-inflammatory antibodies to combat colitis.

This innovative approach enables scientists to effectively communicate with the bacteria, ensuring targeted treatment delivery.

Three pigs were infected with colitis, a type of inflammatory bowel disease with few treatment options currently available – Credit: Connect images via Getty

“This represents a remarkable technological advancement,” stated Dr. Lindsey Edwards, a senior lecturer in Microbiology at King’s College London, as reported by BBC Science Focus. Dr. Edwards was not involved in the research.

“Methods like this enable precise, real-time interactions with gut bacteria and have the potential to revolutionize treatment,” she added.

“There is an urgent need for new tools that allow us to harness the full potential of our microbiota to enhance health and better understand and manage microbial infections.”

At present, colitis has no existing treatments, and options are scarce. Dr. Edwards believes that such future methods could “open new pathways” for treating not only inflammatory bowel disease but also other gut-related conditions, including type 2 diabetes, heart disease, and chronic fatigue.

However, Dr. Alexandre Almeida, from the Department of Veterinary Medicine at Cambridge University and not part of this research, warns that this possibility is still distant.

“This is still a preliminary proof-of-concept study,” he noted. “The technology has only been tested in animals and specifically for detecting certain conditions.”

“Before human applications, we must evaluate the safety of this technology and address significant questions, such as how these engineered microorganisms influence the natural balance of other gut bacteria.”

Dr. Nicholas Ilott, a senior researcher at the Oxford Microbiome Research Center who did not participate in the study, stated that the technology is “incredibly exciting” and could prove to be “very valuable” in future medical treatments.

Read more:

About our experts

Dr. Lindsey Edwards is a senior lecturer in microbiology at King’s College London, UK. Her research focuses on mucosal barrier immunology, host-microbe interactions, and the priming of adaptive immune responses, along with intestinal and liver diseases.

Dr. Alexandre Almeida is a Principal Investigator and MRC Career Development Fellow at the University of Cambridge, UK, specializing in bioinformatics and genomic approaches for biological discoveries related to human health.

Dr. Nicholas Ilott is a senior researcher specializing in bioinformatics at the Microbiome Research Centre, Nuffield Department of Orthopaedic Surgery, Oxford University, UK, concentrating on host-microbe interactions in chronic liver and inflammatory bowel diseases.

Source: www.sciencefocus.com